LexDanaLexDanabeta
Inventor

HAILIN ZHENG

Inventor
US

Overview

5→
Patents
2022–2025
Patent span
Human necessities
Primary field (CPC A)

Patents· 5 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations36%
C07DHeterocyclic compounds36%
A61KPreparations for medical, dental or toiletry purposes29%
PatentTitleYear
12,331,052Organic compounds202512,180,210Compounds202412,173,004Pharmaceutical compositions comprising heterocycle fused gamma carboline prodrugs202411,773,095Organic compounds202311,427,587Organic compounds2022

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2022–2025Patents assigned to INTRA CELLULAR THERAPIES INC (5)· patent assignee history
2022–2025Based in US· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
INTRA CELLULAR THERAPIES INC52022–2025
Locations
LocationPatentsSpan
US52022–2025